prospectivaconsultoria.com.br

  • Increase font size
  • Default font size
  • Decrease font size
PortuguêsEnglish
Home Clipping Pharmaceutical Industry
Pharmaceutical Industry

Boehringer focuses on oncology and targets Brazil

E-mail Print PDF

The German pharmaceutical Boehringer Ingelheim plans to launch over the next three years oncology drugs from its pipeline in Brazil, and should focus on this segment. The company already makes clinical trial in the country.

See more: Valor Econômico

 

Eurofarma increases partnership with Cuba

E-mail Print PDF

The Brazilian pharmaceutical company Eurofarma extends the joint research and development - R&D of new biotech drugs with Cuban laboratories. The focus is on oncology products.

See more: Valor Econômico  

 

J&J regionalized command in Brazil and focuses on retail and SME

E-mail Print PDF

Johnson & Johnson Brazil (J&J) adopts a model of regionalization with autonomy of the sales teams in its division of consumer goods, which includes OTC. The area of OTC will focus the company's new strategy, including agressive sales models.

See more: Valor Econômico  

 

 MSD is restructuring and will deactivate one of its plants in Brazil

E-mail Print PDF

The Merck Sharp & Dohme (MSD, as it is known in Brazil) in its process of operational restructuring with the activities of Schering-Plough, will deactivate one of its plants in Brazil, while investing in the expansion of other plant to turn it in export platform to Latin America. The American Pharmaceutical company has 3 plants of drugs in Brazil. 

See more: Valor Econômico 

 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  •  End 
  • »


Page 1 of 55